18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non–small cell lung cancer

K Higashi, Y Ueda, Y Arisaka, T Sakuma… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Among patients with resected non–small cell lung cancer (NSCLC), approximately 50% present
with a recurrent tumor. The clinical or pathologic TNM staging does not always provide a …

Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

K Kaira, T Higuchi, I Naruse, Y Arisaka, A Tokue… - European journal of …, 2018 - Springer
Background Nivolumab, an anti-programmed death-1 (PD-1) antibody, is administered in
patients with previously treated non-small cell lung cancer. However, little is known about the …

[PDF][PDF] FDG PET measurement of the proliferative potential of non-small cell lung cancer

K Higashi, Y Ueda, M Yagishita, Y Arisaka… - Journal of Nuclear …, 2000 - Soc Nuclear Med
The goals of this study were to correlate FDG uptake with cell proliferation and cellular density
in non— smallcell lung cancer. Methods: Thirty-one patients with 32 non— smallcell …

The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT

K Okamura, Y Yonemoto, Y Arisaka, K Takeuchi… - …, 2012 - academic.oup.com
Objectives. To evaluate whether there is a correlation between the differences in joint uptake
of 2-[18F]-fluoro-2-deoxy-d-glucose ( 18 F-FDG) and the improvement of clinical findings in …

Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma

N Kasahara, K Kaira, P Bao, T Higuchi, Y Arisaka… - Lung Cancer, 2018 - Elsevier
Objectives 2-Deoxy-2-[fluorine-18] fluoro-d-glucose with positron emission tomography ( 18
F-FDG-PET) is a clinically useful tool for cancer evaluation. F-FDG accumulation in tumor …

Clinical and biological significance of PD-L1 expression within the tumor microenvironment of oral squamous cell carcinoma

H Takahashi, K Sakakura, Y Arisaka, A Tokue… - Anticancer …, 2019 - ar.iiarjournals.org
Background/Aim: Programmed death-ligand 1 (PD-L1) expression in tumor cells is regulated
by a close interrelation between tumor and stromal cells within the tumor microenvironment…

Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron …

…, A Taketomi-Takahashi, T Nakajima, Y Arisaka… - Annals of nuclear …, 2008 - Springer
Objective To investigate the diagnostic features of whole-body diffusion-weighted magnetic
resonance imaging (DWI) as compared with 2-[ 18 F]-fluoro-2-deoxy-d-glucose positron …

Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy

…, N Oriuchi, T Higuchi, G Miyashita, Y Arisaka… - Annals of nuclear …, 2010 - Springer
Objective Clinical application of FDG-PET in head and neck cancer includes identification of
metastases, unknown primary head and neck malignancy, or second primary carcinoma, …

Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands

A Tokue, T Higuchi, Y Arisaka, T Nakajima… - Annals of nuclear …, 2015 - Springer
Purpose The aim of the current study was to evaluate the utility of F-18-fluoro-2-deoxy-d-glucose
(F-18 FDG) positron emission tomography/computed tomography (PET/CT) in …

Clinical significance of 18F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with 18F …

M Kim, T Higuchi, Y Arisaka, A Achmad… - Annals of nuclear …, 2013 - Springer
Clinical significance of 18F-α-methyl tyrosine PET/CT for the detection of bone marrow
invasion in patients with oral squamous cell carcinoma: comparison with 18F-FDG PET/CT and …